Last 48 quarters of trend data · Healthcare · Metabolic & Cardiovascular Biotech
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -12.63 | 285.09 | — | — | — | — | — | — | — | — | 46.49 | — | — | — | — | — | 144.05 | — | — | — | 21.06 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +583.9% | — | — | — | -82.8% | |
| P/S Ratio | 1.37 | 1.71 | 1.97 | 1.68 | 1.48 | 1.71 | 1.16 | 1.10 | 0.80 | 1.52 | 1.05 | 1.62 | 1.18 | 1.42 | 1.51 | 1.77 | 1.35 | 1.23 | 1.57 | 3.46 | 2.34 |
| — | -0.1% | +70.2% | +52.6% | +84.7% | +12.4% | +10.3% | -31.9% | -32.2% | +7.1% | -30.8% | -8.8% | -12.4% | +15.9% | -3.6% | -48.8% | -42.5% | -65.5% | -44.8% | -19.8% | -19.7% | |
| P/B Ratio | 0.52 | 0.61 | 0.75 | 0.67 | 0.63 | 0.74 | 0.72 | 0.39 | 0.41 | 0.49 | 0.51 | 0.67 | 0.64 | 0.68 | 0.85 | 1.04 | 0.82 | 0.75 | 1.02 | 2.04 | 2.03 |
| — | -17.9% | +3.5% | +72.7% | +54.2% | +52.9% | +41.0% | -41.7% | -36.3% | -28.6% | -39.9% | -35.8% | -21.2% | -9.5% | -16.6% | -49.0% | -59.8% | -76.2% | -62.5% | -47.1% | -34.7% | |
| P/FCF | 3.40 | 7.34 | 2.06 | 11.86 | 4.75 | — | 5.06 | 966.30 | — | — | — | — | — | 12.76 | — | — | — | — | — | — | — |
| — | — | -59.3% | -98.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | 78.70 | — | — | — | — | — | — | — | — | — | 16.90 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -70.8% | |
| EV / EBIT | — | 96.66 | — | — | — | — | 7.22 | — | — | — | 6.45 | — | — | — | — | — | — | — | — | — | 17.81 |
| — | — | — | — | — | — | +11.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | -68.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.6% | 40.9% | 35.5% | 39.4% | 45.6% | 44.7% | 69.2% | 59.8% | -15.4% | 38.5% | 62.2% | 56.4% | 59.4% | 45.1% | 53.2% | 55.7% | 70.5% | 69.9% | 46.2% | 76.5% | 78.8% |
| — | -8.5% | -48.7% | -34.2% | +397.3% | +16.2% | +11.2% | +6.0% | -125.8% | -14.8% | +16.9% | +1.3% | -15.7% | -35.4% | +15.2% | -27.1% | -10.6% | -11.2% | -41.7% | -4.5% | -0.5% | |
| Operating Margin | -6.5% | -6.0% | -28.4% | -17.8% | -4.6% | -22.4% | -22.0% | -39.9% | -84.3% | -59.5% | -0.8% | -24.0% | -6.2% | -32.5% | -29.9% | -20.2% | -10.6% | -5.7% | -66.5% | -29.9% | 11.2% |
| — | +73.3% | -29.0% | +55.5% | +94.6% | +62.4% | -2730.4% | -65.9% | -1266.8% | -83.2% | +97.4% | -19.2% | +41.9% | -467.4% | +55.1% | +32.6% | -195.1% | +37.8% | -1271.6% | -3095.2% | +160.9% | |
| Net Margin | -18.2% | 0.6% | -18.1% | -23.3% | -2.5% | -15.6% | -19.4% | -37.4% | -78.0% | -59.4% | 2.3% | -17.6% | -7.7% | -29.2% | -21.9% | -19.1% | 0.9% | -5.7% | -74.1% | -33.4% | 10.2% |
| — | +104.0% | +6.8% | +37.7% | +96.8% | +73.8% | -961.9% | -112.1% | -908.5% | -103.3% | +110.3% | +8.0% | -915.8% | -411.2% | +70.4% | +42.6% | -90.7% | +38.2% | -1565.6% | -2816.3% | +245.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -8.2% | 0.1% | -1.7% | -2.3% | -0.3% | -1.7% | -3.0% | -3.3% | -9.6% | -4.6% | 0.3% | -1.8% | -1.1% | -3.4% | -3.0% | -2.8% | 0.1% | -0.9% | -11.5% | -4.8% | 2.2% |
| — | +103.3% | +43.1% | +29.3% | +97.2% | +63.9% | -1185.3% | -80.4% | -805.6% | -34.8% | +109.1% | +35.0% | -829.2% | -291.0% | +73.4% | +42.2% | -93.6% | +56.9% | -1039.1% | -1772.5% | +181.3% | |
| ROA | -5.7% | 0.0% | -1.2% | -1.6% | -0.2% | -1.2% | -2.1% | -2.3% | -6.8% | -3.2% | 0.2% | -1.2% | -0.7% | -2.3% | -2.0% | -1.9% | 0.1% | -0.5% | -7.2% | -3.1% | 1.4% |
| — | +103.3% | +43.5% | +31.8% | +97.3% | +64.1% | -1212.6% | -90.7% | -870.0% | -42.6% | +109.4% | +34.9% | -831.8% | -316.0% | +71.6% | +39.0% | -93.2% | +56.8% | -1036.6% | -1760.2% | +173.2% | |
| ROIC | -2.9% | -0.6% | -2.9% | -1.8% | -0.5% | -2.5% | -3.5% | -3.4% | -10.4% | -5.2% | -0.1% | -2.9% | -1.1% | -5.1% | -4.8% | -3.3% | -1.9% | -1.1% | -11.9% | -4.8% | 2.7% |
| — | +76.4% | +18.3% | +46.8% | +95.2% | +52.0% | -2934.6% | -17.7% | -876.5% | -2.9% | +97.6% | +11.7% | +44.7% | -371.0% | +59.5% | +31.2% | -170.6% | +58.7% | -712.8% | -1820.6% | +121.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| — | +16.8% | -24.9% | -25.9% | +66.7% | -5.1% | +7.6% | +9.1% | +0.4% | -4.7% | -11.8% | -8.7% | -5.9% | -4.0% | -5.1% | +3.8% | +30.9% | +24.3% | +27.5% | +14.2% | -11.9% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 34.13 | — | — | — | — | — | — | — | — | — | 0.51 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -57.5% | |
| Current Ratio | 3.34 | 3.50 | 3.67 | 3.48 | 3.34 | 3.45 | 3.26 | 3.53 | 3.31 | 3.23 | 3.04 | 3.07 | 2.80 | 2.69 | 2.61 | 2.80 | 2.66 | 2.39 | 1.99 | 2.57 | 2.37 |
| — | +1.5% | +12.5% | -1.2% | +1.0% | +6.9% | +7.2% | +15.1% | +18.3% | +19.9% | +16.7% | +9.5% | +5.3% | +12.6% | +31.1% | +8.9% | +12.0% | -9.5% | -26.0% | -10.0% | -17.1% | |
| Quick Ratio | 2.33 | 2.59 | 2.67 | 2.46 | 2.33 | 2.43 | 2.34 | 2.55 | 2.39 | 2.11 | 2.01 | 1.93 | 1.80 | 1.74 | 1.77 | 1.88 | 1.77 | 1.60 | 1.36 | 1.68 | 1.74 |
| — | +6.5% | +14.1% | -3.3% | -2.2% | +15.1% | +16.8% | +32.1% | +32.6% | +21.8% | +13.3% | +2.8% | +1.4% | +8.7% | +29.7% | +11.7% | +2.1% | -10.9% | -30.1% | -21.8% | -22.6% | |
| Interest Coverage | -5148.71 | — | — | — | — | — | — | — | -5416.86 | — | — | — | -307.78 | — | — | — | -21213.00 | — | — | — | 697.61 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AMRN stock.
Amarin Corporation plc's current P/E is -12.6x. The average P/E over the last 1 quarters is 285.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Amarin Corporation plc's current operating margin is -6.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Amarin Corporation plc's business trajectory between earnings reports.